Department of Medicinal Chemistry, Orion Corporation Orion Pharma, Orionintie 1, PL 65, FI-02101, Finland.
Department of Medicinal Chemistry, Orion Corporation Orion Pharma, Orionintie 1, PL 65, FI-02101, Finland.
Bioorg Med Chem Lett. 2022 Dec 1;77:129005. doi: 10.1016/j.bmcl.2022.129005. Epub 2022 Sep 26.
Here is reported the design and synthesis of a series of highly potent and selective α2C antagonists using benzodioxine methyl piperazine as a central scaffold by pharmacophoric analysis to improve the pharmacokinetics of suboptimal clinical candidate molecules.
本文报道了一系列高活性和选择性的α2C 拮抗剂的设计和合成,以苯并二氧杂环戊烷甲基哌嗪为中心骨架,通过药效团分析来改善次优临床候选分子的药代动力学性质。